Comparative Pharmacology
Head-to-head clinical analysis: ACHROMYCIN versus SEYSARA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACHROMYCIN versus SEYSARA.
ACHROMYCIN vs SEYSARA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA from binding to the A site.
Sarecycline is a tetracycline-class antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the addition of amino acids to the growing peptide chain. It also has anti-inflammatory properties through inhibition of neutrophil chemotaxis and reduction of pro-inflammatory cytokines.
250-500 mg orally every 6 hours or 500 mg intravenously every 12 hours.
100 mg orally once daily with food.
None Documented
None Documented
6-12 hours; prolonged to 48-72 hours in severe renal impairment
The terminal elimination half-life after oral administration is approximately 12 hours (range 10-14 hours), supporting once-daily dosing.
Renal (60-80% unchanged via glomerular filtration); biliary/fecal (10-20%)
Renal excretion of unchanged drug accounts for approximately 66% of the administered dose; fecal elimination is about 33%.
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic